Charles Sinclair is currently the Vice President and Head of Translational Sciences at Flagship Pioneering’s Pioneering Medicines, where they lead Translational Research and Bioinformatics functions and support a wide portfolio across various therapeutic areas. Previously, they held leadership positions at Bristol Myers Squibb and AstraZeneca, where they were instrumental in the discovery of clinical candidates and managed research groups in oncology and immuno-oncology. Charles completed their Ph.D. in Immunology at the MRC National Institute for Medical Research and is pursuing a Bachelor's Degree in Biological Sciences at the University of Warwick.
This person is not in any teams
This person is not in any offices